Your browser doesn't support javascript.
loading
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma.
Fehniger, Todd A; Watkins, Marcus P; Ezenwajiaku, Nkiruka; Wan, Fei; Hurd, David D; Cashen, Amanda F; Blum, Kristie A; Goy, Andre; Fenske, Timothy S; Wagner-Johnston, Nina D; Carson, Kenneth; Siegel, Marilyn J; Russler-Germain, David; Schneider, Stephanie E; Mehta-Shah, Neha; Kahl, Brad; Bartlett, Nancy L.
Affiliation
  • Fehniger TA; Washington University School of Medicine, Division of Oncology, St. Louis, MO. tfehnige@wustl.edu.
  • Watkins MP; Washington University School of Medicine, Division of Oncology, St. Louis, MO.
  • Ezenwajiaku N; Washington University School of Medicine, Division of Oncology, St. Louis, MO.
  • Wan F; Washington University School of Medicine, Division of Biostatistics, St. Louis, MO.
  • Hurd DD; Wake Forest University School of Medicine, Section of Hematology and Oncology, Winston-Salem, NC.
  • Cashen AF; Washington University School of Medicine, Division of Oncology, St. Louis, MO.
  • Blum KA; Emory University School of Medicine, Atlanta, GA.
  • Goy A; Hackensack University Medical Center, Division of Lymphoma, Hackensack, NJ.
  • Fenske TS; Medical College of Wisconsin, Hematology and Oncology, Milwaukee, WI.
  • Wagner-Johnston ND; Washington University School of Medicine, Division of Oncology, St. Louis, MO.
  • Carson K; Washington University School of Medicine, Division of Oncology, St. Louis, MO.
  • Siegel MJ; Washington University, Mallinckrodt Institute of Radiology, Alvin J. Siteman Cancer Center, St. Louis, MO.
  • Russler-Germain D; Washington University School of Medicine, Division of Oncology, St. Louis, MO.
  • Schneider SE; Washington University School of Medicine, Division of Oncology, St. Louis, MO.
  • Mehta-Shah N; Washington University School of Medicine, Division of Oncology, St. Louis, MO.
  • Kahl B; Washington University School of Medicine, Division of Oncology, St. Louis, MO.
  • Bartlett NL; Washington University School of Medicine, Division of Oncology, St. Louis, MO. nbarlet@wuslt.edu.
Haematologica ; 109(3): 953-957, 2024 Mar 01.
Article in En | MEDLINE | ID: mdl-37706336
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease Limits: Humans Language: En Journal: Haematologica Year: 2024 Type: Article Affiliation country: Macao
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease Limits: Humans Language: En Journal: Haematologica Year: 2024 Type: Article Affiliation country: Macao